{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:13:36Z","timestamp":1790806416067,"version":"4.1.0"},"reference-count":104,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T00:00:00Z","timestamp":1612310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Beh\u00e7et's Disease (BD) is a systemic vasculitis firstly described as a disorder causing aphthous lesion in oral and genital mucosae and uveitis. The disease has an extremely unique distribution characterized by the highest incidence in communities living along the historical Silk road. Although our understanding of the etiopathogenesis of BD has expanded over time, there are still lots of unidentified points in the underlying mechanisms of the disease. The accepted opinion in the light of the current knowledge is that various identified and\/or unidentified infectious and\/or environmental triggers can take a role as a trigger in individuals with genetic susceptibility. Although the disease usually develops in young adulthood, it is reported that about 15\u201320% of all Beh\u00e7et's patients develop in childhood. Pediatric BD differs from adult BD not only with the age of onset but also in the frequency and distribution of clinical findings, disease severity and outcome. While gastrointestinal system involvement, neurological findings, arthralgia and positive family history are more common in children, genital lesions and vascular lesions are more common in adult patients. In addition, a better disease outcome with lower severity score and activity index has been reported in children. The diagnosis of the disease is made according to clinical findings. It can be challenging to diagnose the disease due to the absence of a specific diagnostic test, and the long time interval from the first finding of the disease to the full-blown disease phenotype in pediatric cases. Therefore, many classification criteria have been proposed so far. The widely accepted ones are proposed by the International Study Group. The new sets of classification criteria which is the only one for pediatric BD were also developed for pediatric cases by the PEDBD group. The primary goal for the treatment is preventing the organ damages by suppressing the ongoing inflammation and forestalling the disease flares. The treatment of the BD can be onerous due to its multisystemic nature and a multidisciplinary approach is essential for the management of the patients. In this review article, the definition, clinical findings, epidemiology, etiopathogenesis, and treatment will be discussed.<\/jats:p>","DOI":"10.3389\/fmed.2021.627192","type":"journal-article","created":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T04:20:33Z","timestamp":1612326033000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":57,"title":["Pediatric Beh\u00e7et's Disease"],"prefix":"10.3389","volume":"8","author":[{"given":"Mehmet","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih","family":"Haslak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amra","family":"Adrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezgin","family":"Sahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oya","family":"Koker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenan","family":"Barut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Kasapcopur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5152\/eurjrheum.2019.19121","article-title":"Pediatric Beh\u00e7et's disease - clinical aspects and current concepts","volume":"7","author":"Yildiz","year":"2019","journal-title":"Eur J Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12969-016-0070-z","article-title":"Behcet's disease in children, an overview","volume":"14","author":"Kone-Paut","year":"2016","journal-title":"Pedia Rheumatol J."},{"key":"B3","doi-asserted-by":"publisher","first-page":"108381","DOI":"10.1016\/j.clim.2020.108381","article-title":"Juvenile-onset Beh\u00e7et's syndrome and mimics","volume":"214","author":"Pain","year":"2020","journal-title":"Clin Immunol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-020-08809-2","article-title":"Clinical manifestations and management of pediatric Beh\u00e7et's disease","author":"Hu","year":"2020","journal-title":"Clin Rev Allergy Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00296-018-4208-9","article-title":"Diagnostic\/classification criteria in pediatric Beh\u00e7et's disease","volume":"39","author":"Batu","year":"2019","journal-title":"Rheumatol Int."},{"key":"B6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-4632.2006.02754.x","article-title":"Clinical features of Beh\u00e7et's disease in children","volume":"45","author":"Borlu","year":"2006","journal-title":"Int J Dermatol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1159\/000018197","article-title":"Twenty-eight cases of juvenile-onset Adamantiades-Beh\u00e7et disease in Germany","volume":"199","author":"Treudler","year":"1999","journal-title":"Dermatology."},{"key":"B8","first-page":"133","article-title":"Beh\u00e7et's disease in patients of German and Turkish origin living in Germany: a comparative analysis","volume":"31","author":"K\u00f6tter","year":"2004","journal-title":"J Rheumatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1136\/ard.28.2.95","article-title":"Beh\u00e7et's syndrome with arthritis","volume":"28","author":"Mason","year":"1969","journal-title":"Ann Rheum Dis."},{"key":"B10","first-page":"1078","article-title":"International Study Group for Behcet's Disease","volume":"335","year":"1990","journal-title":"Lancet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","article-title":"The International Criteria for Beh\u00e7et's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria","volume":"28","year":"2014","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1136\/annrheumdis-2015-208491","article-title":"Consensus classification criteria for paediatric Beh\u00e7et's disease from a prospective observational cohort: PEDBD","volume":"75","author":"Kon\u00e9-Paut","year":"2016","journal-title":"Ann Rheum Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1034\/j.1399-0039.1999.540301.x","article-title":"Beh\u00e7et's disease, the Silk Road and HLA-B51: historical and geographical perspectives","volume":"54","author":"Verity","year":"1999","journal-title":"Tissue Antigens."},{"key":"B14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Beh\u00e7et's disease prevalence: a meta-analytical approach","volume":"57","author":"Maldini","year":"2017","journal-title":"Rheumatology."},{"key":"B15","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1136\/pgmj.68.801.566","article-title":"Beh\u00e7et's syndrome in Scotland","volume":"68","author":"Jankowski","year":"1992","journal-title":"Postgrad Med J."},{"key":"B16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.5152\/balkanmedj.2016.15101","article-title":"Investigation of Beh\u00e7et's disease and recurrent aphthous stomatitis frequency: the highest prevalence in turkey","volume":"33","author":"Ba\u015f","year":"2016","journal-title":"Balkan Med J."},{"key":"B17","first-page":"51","article-title":"The prevalence of Beh\u00e7et's disease in the north of Jordan: a hospital-based epidemiological survey","volume":"35","author":"Madanat","year":"2017","journal-title":"Clin Exp Rheum."},{"key":"B18","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.berh.2018.08.010","article-title":"Update on the epidemiology, risk factors and disease outcomes of Beh\u00e7et's disease","volume":"32","author":"Akko\u00e7","year":"2018","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"B19","first-page":"S125","article-title":"Prevalence of Adamantiades-Behcet's disease in Germany and the municipality of Berlin: results of a nationwide survey","volume":"24","author":"Papoutsis","year":"2006","journal-title":"Clin Exp Rheum."},{"key":"B20","first-page":"471","article-title":"Behcet's disease, hospital-based prevalence and manifestations in the Rotterdam area","volume":"73","author":"Kappen","year":"2015","journal-title":"Netherlands J Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.jaad.2007.10.452","article-title":"Demographic and clinical properties of juvenile-onset Beh\u00e7et's disease: A controlled multicenter study","volume":"58","author":"Karincaoglu","year":"2008","journal-title":"J Am Acad Dermatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1007\/s10067-016-3187-z","article-title":"Paediatric Beh\u00e7et's disease: a UK tertiary centre experience","volume":"35","author":"Nanthapisal","year":"2016","journal-title":"Clin Rheum."},{"key":"B23","doi-asserted-by":"crossref","first-page":"p. 205","DOI":"10.1007\/978-1-4419-5641-5_12","article-title":"Juvenile Beh\u00e7et's Syndrome","volume-title":"Beh\u00e7et's Syndrome","author":"Seyahi","year":"2010"},{"key":"B24","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/ard.43.6.783","article-title":"Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh\u00e7et's syndrome","volume":"43","author":"Yazici","year":"1984","journal-title":"Ann Rheum Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1093\/rheumatology\/keq324","article-title":"Registries in rheumatological and musculoskeletal conditions. Paediatric Beh\u00e7et's disease: an international cohort study of 110 patients. One-year follow-up data","volume":"50","author":"Kon\u00e9-Paut","year":"2010","journal-title":"Rheumatology."},{"key":"B26","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1346-8138.13381","article-title":"Beh\u00e7et's disease: a comprehensive review with a focus on epidemiology, etiology and clinical features, and management of mucocutaneous lesions","volume":"43","author":"Alpsoy","year":"2016","journal-title":"J Dermatol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.semarthrit.2020.01.013","article-title":"Characteristics of pediatric Beh\u00e7et's disease in Turkey and Israel: A cross-sectional cohort comparison","volume":"50","author":"Butbul Aviel","year":"2020","journal-title":"Sem Arthritis Rheum."},{"key":"B28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.autrev.2017.12.006","article-title":"Beh\u00e7et's disease: New insights into pathophysiology, clinical features and treatment options","volume":"17","author":"Greco","year":"2018","journal-title":"Autoimmun Rev."},{"key":"B29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s12016-012-8319-x","article-title":"Beh\u00e7et syndrome: is it one condition?","volume":"43","author":"Yazici","year":"2012","journal-title":"Clin Rev Allergy Immunol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11739-019-02046-y","article-title":"Phenotypes in Beh\u00e7et's syndrome","volume":"14","author":"Seyahi","year":"2019","journal-title":"Internal Emerg Med."},{"key":"B31","first-page":"1152","article-title":"On relapsing, aphthous ulcers of the mouth, eye and genitelia caused by a virus","volume":"105","author":"Bechet","year":"1937","journal-title":"Dermat Wochsch."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","article-title":"Beh\u00e7et's Disease: an overview of etiopathogenesis","volume":"10","author":"Leccese","year":"2019","journal-title":"Front Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/08830189709116842","article-title":"The role of heat shock protein, microbial and autoimmune agents in the aetiology of Behget's disease","volume":"14","author":"Lehner","year":"1997","journal-title":"Int Rev Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1348-0421.1992.tb02083.x","article-title":"Antibody response to oral streptococci in Beh\u00e7et's disease","volume":"36","author":"Yokota","year":"1992","journal-title":"Microbiol Immunol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nrrheum.2017.208","article-title":"Beh\u00e7et syndrome: a contemporary view","volume":"14","author":"Yazici","year":"2018","journal-title":"Nat Rev Rheumatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clim.2016.06.002","article-title":"Sequencing of 16S rRNA reveals a distinct salivary microbiome signature in Beh\u00e7et's disease","volume":"169","author":"Coit","year":"2016","journal-title":"Clin Immunol."},{"key":"B37","first-page":"1029","article-title":"Induction of Behcet's disease symptoms after dental treatment and streptococcal antigen skin test","volume":"15","author":"Mizushima","year":"1988","journal-title":"J Rheumatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0153746","DOI":"10.1371\/journal.pone.0153746","article-title":"Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet's disease","volume":"11","author":"Shimizu","year":"2016","journal-title":"PLoS ONE."},{"key":"B39","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.autrev.2014.11.009","article-title":"Beh\u00e7et's syndrome patients exhibit specific microbiome signature","volume":"14","author":"Consolandi","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of Beh\u00e7et's disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthr Rheum."},{"key":"B41","doi-asserted-by":"crossref","first-page":"p. 11","DOI":"10.1007\/978-1-4939-8546-3_2","article-title":"Role of human leukocyte antigens (HLA) in autoimmune diseases","volume-title":"HLA Typing: Methods and Protocols","author":"Bodis","year":"2018"},{"key":"B42","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","article-title":"Relationships of HLA-B51 or B5 genotype with Beh\u00e7et's disease clinical characteristics: systematic review and meta-analyses of observational studies","volume":"51","author":"Maldini","year":"2012","journal-title":"Rheumatology."},{"key":"B43","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/1547691X.2017.1346008","article-title":"Genetics and immunodysfunction underlying Beh\u00e7et's disease and immunomodulant treatment approaches","volume":"14","author":"Salmaninejad","year":"2017","journal-title":"J Immunotoxicol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/BOR.0000000000000189","article-title":"Endoplasmic reticulum-associated amino-peptidase 1 and rheumatic disease: genetics","volume":"27","author":"Ombrello","year":"2015","journal-title":"Curr Opin Rheumatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/ng0911-919a","article-title":"Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility","volume":"43","author":"Evans","year":"2011","journal-title":"Nat Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/ng.694","article-title":"A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1","volume":"42","author":"Strange","year":"2010","journal-title":"Nat Gen."},{"key":"B47","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1097\/BOR.0b013e328363ea8b","article-title":"Pediatric-onset Behcet disease","volume":"25","author":"Ozen","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1002\/art.24763","article-title":"HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats","volume":"60","author":"DeLay","year":"2009","journal-title":"Arthr Rheum."},{"key":"B49","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nrrheum.2015.147","article-title":"MHC-I-opathy-unified concept for spondyloarthritis and Beh\u00e7et disease","volume":"11","author":"McGonagle","year":"2015","journal-title":"Nat Rev Rheumatol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-3476(99)70333-1","article-title":"Familial aggregation in Beh\u00e7et's disease: high frequency in siblings and parents of pediatric probands","volume":"135","author":"Kon\u00e9-Paut","year":"1999","journal-title":"J Pediatr."},{"key":"B51","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1136\/ard.59.8.622","article-title":"Familial aggregation of Beh\u00e7et's disease in Turkey","volume":"59","author":"G\u00fcl","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"14405","DOI":"10.1073\/pnas.2002051117","article-title":"Common genetic susceptibility loci link PFAPA syndrome, Beh\u00e7et's disease, and recurrent aphthous stomatitis","volume":"117","author":"Manthiram","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B53","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10067-015-2890-5","article-title":"PFAPA syndrome and Beh\u00e7et's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists","volume":"35","author":"Cantarini","year":"2016","journal-title":"Clin Rheum."},{"key":"B54","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4274\/balkanmedj.galenos.2020.2020.4.82","article-title":"Autoinflammatory Diseases in Childhood","volume":"37","author":"Yildiz","year":"2020","journal-title":"Balkan Med J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s00296-018-4105-2","article-title":"Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences","volume":"39","author":"Adrovic","year":"2019","journal-title":"Rheumatol Int."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05466-w","article-title":"Independent risk factors for resolution of periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome within 4 years after the disease onset","author":"Yildiz","year":"2020","journal-title":"Clin Rheum."},{"key":"B57","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1365-2133.2007.08116.x","article-title":"Clinical features and natural course of Beh\u00e7et's disease in 661 cases: a multicentre study","volume":"157","author":"Alpsoy","year":"2007","journal-title":"Br J Dermatol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3109\/09273948.2011.555592","article-title":"Beh\u00e7et Disease in Children","volume":"19","author":"Atmaca","year":"2011","journal-title":"Ocular Immunology and Inflammation."},{"key":"B59","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1093\/rheumatology\/38.5.457","article-title":"Childhood Beh\u00e7et's disease: clinical features and comparison with adult-onset disease","volume":"38","author":"Krause","year":"1999","journal-title":"Rheumatology."},{"key":"B60","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Beh\u00e7et's disease - a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J Autoimmun."},{"key":"B61","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/rheumatology\/31.11.767","article-title":"Clinical differantation of oral ulceration in Beh\u00e7et's disease","volume":"31","author":"Main","year":"1992","journal-title":"Rheumatology."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1136\/bjo.2008.154476","article-title":"Low prevalence of juvenile-onset Beh\u00e7et's disease with uveitis in East\/South Asian people","volume":"93","author":"Kitaichi","year":"2009","journal-title":"Br J Ophthalmol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000442667","article-title":"Juvenile Adamantiades-Beh\u00e7et Disease","volume":"232","author":"Vaiopoulos","year":"2016","journal-title":"Dermatology."},{"key":"B64","first-page":"135","article-title":"Paediatric Beh\u00e7et's disease in Iran: report of 204 cases","volume":"36","author":"Shahram","year":"2018","journal-title":"Clin Exp Rheum."},{"key":"B65","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12969-017-0213-x","article-title":"A national cohort study on pediatric Beh\u00e7et's disease: cross-sectional data from an Italian registry","volume":"15","author":"Gallizzi","year":"2017","journal-title":"Pediat Rheum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"495","DOI":"10.2147\/TCRM.S232660","article-title":"Beh\u00e7et's Disease in Children: Diagnostic and Management Challenges","volume":"16","author":"Costagliola","year":"2020","journal-title":"Ther Clin Risk Manag."},{"key":"B67","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1002\/art.21231","article-title":"Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in beh\u00e7et's disease: An open-label trial","volume":"52","author":"Tugal-Tutkun","year":"2005","journal-title":"Arthr Rheum."},{"key":"B68","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0022-3476(98)70368-3","article-title":"Clinical features of Beh\u00e7et's disease in children: an international collaborative study of 86 cases","volume":"132","author":"Kon\u00e9-Paut","year":"1998","journal-title":"J Pediat."},{"key":"B69","first-page":"502","article-title":"Juvenile Behcet's disease in Israel. The pediatric rheumatology study group of Israel","volume":"16","author":"Uziel","year":"1998","journal-title":"Clin Exp Rheum."},{"key":"B70","first-page":"309","article-title":"Behcets disease in children","volume":"39","author":"Pivetti-Pezzi","year":"1995","journal-title":"Jap J Ophthalmol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.survophthal.2005.04.009","article-title":"Current concepts in the etiology and treatment of Beh\u00e7et disease","volume":"50","author":"Evereklioglu","year":"2005","journal-title":"Survey Ophthalmol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1756-185X.2010.01549.x","article-title":"Behcet's disease in Iran: analysis of 6500 cases","volume":"13","author":"Davatchi","year":"2010","journal-title":"Int J Rheum Dis."},{"key":"B73","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14744\/TurkPediatriArs.2019.15045","article-title":"Beh\u00e7et's disease in children: single-center experience","volume":"54","author":"\u00c7irkinoglu","year":"2019","journal-title":"Turk Pediatri Ars."},{"key":"B74","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1093\/brain\/122.11.2171","article-title":"Clinical patterns of neurological involvement in Beh\u00e7et's disease: evaluation of 200 patients. The Neuro-Beh\u00e7et Study Group","author":"Akman-Demir","year":"1999","journal-title":"Brain."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1212\/WNL.0b013e318238edeb","article-title":"Clinical characteristics of pediatric-onset neuro-Beh\u00e7et disease","volume":"77","author":"Uluduz","year":"2011","journal-title":"Neurology."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/art.38351","article-title":"Long-term outcome of neuro-Beh\u00e7et's disease","volume":"66","author":"Noel","year":"2014","journal-title":"Arthr Rheum."},{"key":"B77","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/BOR.0b013e3283410088","article-title":"Major vessel involvement in Behcet's disease: an update","volume":"23","author":"Calamia","year":"2011","journal-title":"Curr Opin Rheumatol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1097\/00005792-200301000-00006","article-title":"The long-term mortality and morbidity of Beh\u00e7et syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center","volume":"82","author":"Kural-Seyahi","year":"2003","journal-title":"Medicine."},{"key":"B79","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.clindermatol.2017.06.004","article-title":"Beh\u00e7et disease: New aspects","volume":"35","author":"Bulur","year":"2017","journal-title":"Clin Derma."},{"key":"B80","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1097\/00004836-200003000-00006","article-title":"Gastrointestinal manifestations of Behcet's disease","volume":"30","author":"Bayraktar","year":"2000","journal-title":"J Clin Gastroenterol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1055\/s-0028-1103481","article-title":"Differential diagnosis of intestinal Behcet's disease and Crohn's disease by colonoscopic findings","volume":"41","author":"Lee","year":"2009","journal-title":"Endoscopy."},{"key":"B82","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.3748\/wjg.v21.i13.3801","article-title":"Gastrointestinal Behcet's disease: a review","volume":"21","author":"Skef","year":"2015","journal-title":"World J Gastroenterol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.semarthrit.2014.10.014","article-title":"An outcome survey of 43 patients with Budd-Chiari syndrome due to Beh\u00e7et's syndrome followed up at a single, dedicated center","volume":"44","author":"Seyahi","year":"2015","journal-title":"Sem Arthr Rheum."},{"key":"B84","doi-asserted-by":"publisher","first-page":"607921","DOI":"10.1155\/2012\/607921","article-title":"Diagnosis\/Classification Criteria for Behcet's Disease","volume":"2012","author":"Davatchi","year":"2012","journal-title":"Pathol Res Int."},{"key":"B85","first-page":"119","article-title":"The performance of different classification criteria in paediatric Behcet's disease","volume":"35","author":"Batu","year":"2017","journal-title":"Clin Exp Rheum."},{"key":"B86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/1744666X.2021.1834853","article-title":"Evaluation of different classification criteria in children with Behcet disease: results from a single referral center","volume":"2020","author":"Ekinci","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"690390","DOI":"10.1155\/2012\/690390","article-title":"Clinical and pathological manifestations with differential diagnosis in Beh\u00e7et's disease","volume":"2012","author":"Kokturk","year":"2012","journal-title":"Pathol Res Int."},{"key":"B88","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/nrrheum.2012.156","article-title":"Differential diagnosis and management of Beh\u00e7et syndrome","volume":"9","author":"Ambrose","year":"2013","journal-title":"Nat Rev Rheum."},{"key":"B89","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1136\/annrheumdis-2018-213225","article-title":"2018 update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"77","author":"Hatemi","year":"2018","journal-title":"Ann Rheum Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.2165\/00003495-200767140-00004","article-title":"Standard and novel therapeutic approaches to Beh\u00e7et's disease","volume":"67","author":"Gul","year":"2007","journal-title":"Drugs."},{"key":"B91","doi-asserted-by":"publisher","first-page":"iii108","DOI":"10.1093\/rheumatology\/keaa086","article-title":"Management of Behcet's syndrome","volume":"59","author":"Karadag","year":"2020","journal-title":"Rheumatology."},{"key":"B92","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.semarthrit.2018.05.008","article-title":"Management of skin, mucosa and joint involvement of Beh\u00e7et's syndrome: a systematic review for update of the EULAR recommendations for the management of Beh\u00e7et's syndrome","volume":"48","author":"Leccese","year":"2019","journal-title":"Sem Arthr Rheum."},{"key":"B93","doi-asserted-by":"publisher","first-page":"140","DOI":"10.4103\/0974-620X.122267","article-title":"Pediatric uveitis: an update","volume":"6","author":"Majumder","year":"2013","journal-title":"J Oman J Ophthalmol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s11739-019-02035-1","article-title":"Update on the treatment of Beh\u00e7et's syndrome","volume":"14","author":"Esatoglu","year":"2019","journal-title":"J Intern Emerg Med."},{"key":"B96","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/1529-0131(200111)44:11<2686::AID-ART448>3.0.CO;2-H","article-title":"A double-blind trial of colchicine in Beh\u00e7et's syndrome","volume":"44","author":"Yurdakul","year":"2001","journal-title":"Arthr Rheum."},{"key":"B97","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1750-1172-8-18","article-title":"Neuro-Beh\u00e7et's disease in childhood: a focus on the neuro-ophthalmological features","volume":"8","author":"Mora","year":"2013","journal-title":"Orphanet J Rare Dis."},{"key":"B98","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1089\/jop.1994.10.553","article-title":"Low dose cyclosporin-a therapy in Behcet's disease","volume":"10","author":"Sajjadi","year":"1994","journal-title":"J Ocular Pharmacol Ther."},{"key":"B99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.semarthrit.2010.09.002","article-title":"Anti-TNF agents for Beh\u00e7et's disease: analysis of published data on 369 patients","volume":"41","author":"Arida","year":"2011","journal-title":"Sem Arthr Rheum."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/j.ophtha.2014.04.042","article-title":"Evaluation of the long-term efficacy and safety of infliximab treatment for uveitis in Beh\u00e7et's disease: a multicenter study","volume":"121","author":"Takeuchi","year":"2014","journal-title":"Ophthalmology."},{"key":"B101","doi-asserted-by":"publisher","first-page":"e3348","DOI":"10.1097\/MD.0000000000003348","article-title":"Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet's syndrome: a strobe-compliant observational study from a dedicated multidisciplinary center","volume":"95","author":"Hatemi","year":"2016","journal-title":"Medicine."},{"key":"B102","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semarthrit.2003.09.010","article-title":"The use of interferon \u03b1 in beh\u00e7et disease: review of the literature","volume":"33","author":"K\u00f6tter","year":"2004","journal-title":"Sem Arthr Rheum."},{"key":"B103","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1080\/13543784.2016.1181751","article-title":"New therapeutic solutions for Beh\u00e7et's syndrome","volume":"25","author":"Vitale","year":"2016","journal-title":"Exp Opin Invest Drugs."},{"key":"B104","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1056\/NEJMoa1816594","article-title":"Trial of apremilast for oral ulcers in Beh\u00e7et's syndrome","volume":"381","author":"Hatemi","year":"2019","journal-title":"N Engl J Med."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.627192\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,3]],"date-time":"2021-02-03T04:20:42Z","timestamp":1612326042000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2021.627192\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,3]]},"references-count":104,"alternative-id":["10.3389\/fmed.2021.627192"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2021.627192","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,3]]},"article-number":"627192"}}